Good Reasons to Vaccinate: COVID19 Vaccine, Mandatory or Payment Model?

By Julian Savulescu. The best chance of bringing the Coronavirus pandemic to an end with the least loss of life and the greatest return  to normality seems to be the introduction of an effective vaccine. But how should such a vaccine be distributed? To be effective, particularly in protecting the most vulnerable in the population, […]

Read More…

Government-Sanctioned Health Care Discrimination During a Pandemic: Legally Nonsensical and Morally Bereft

By Charles Binkley and David S. Kemp The Trump administration recently announced a rule change that would effectively remove nondiscrimination protections for LGBTQ people in health care and health insurance. Section 1557 of the Affordable Care Act (ACA) prohibits discrimination in the provision of health care on the basis of “race, color, national origin, sex, […]

Read More…

It’s not catastrophizing if it’s a catastrophe: lessons from the pandemic for psychotherapy.

By Sahanika Ratnayake The pandemic seems to have shaken the orthodox understanding of mental health. Instead of seeing mental illnesses —  such as depression and anxiety — or psychological distress as being based primarily in the individual and their various patterns of thoughts, behaviours and emotions (the approach favoured by the DSM), the pandemic exposed […]

Read More…

Why “human challenge” vaccine trials for COVID-19 are morally permissible, but only if we lock down, test, and contact-trace properly

By Ben Bramble We urgently need a vaccine for COVID-19, in order to fully end our lockdowns. The trouble is such vaccines usually take years to develop and test for efficacy and safety. Recently, a number of bioethicists have proposed “human challenge” vaccine trials to speed up the testing process. These involve volunteers receiving a […]

Read More…

Finding a vaccine against the novel coronavirus: why challenge trials can be ethical even when a lot remains unknown

By Robert Steel, Lara Buchak, Nir Eyal Multiple authors believe that the development of coronavirus vaccines could be substantially accelerated through the use of challenge trials, in which participants are deliberately exposed to the virus. The tremendous loss of life and health and significant social and economic upheaval from ongoing worldwide pandemic make acceleration of […]

Read More…

Utilizing parents to hand-bag ventilate when resources are scarce: Is it ethical?

By Emily E. Barsky and Sadath Sayeed Amidst the COVID-19 pandemic, many nations are coping with what resource limited settings are all too familiar with—ventilator scarcity.  In low-income countries, people— and particularly children— frequently die of reversible, acute respiratory failure due to across-the-board resource scarcity.  Some such settings have responded to this by allowing parents […]

Read More…

COVID-19 is a wake-up call for ethical health communication

By Jamie Carlin Watson Increased understanding of social determinants of health and health literacy have expanded the responsibilities of the medical community from patients in the clinic to citizens at increased health risks. Fulfilling these responsibilities involves, in part, distributing timely and accurate health information that is accessible, understandable, and usable. Though increased commitment to […]

Read More…

Surgery in COVID-19 Crisis Conditions: Can We Protect Our Ethical Integrity Against the Odds?

By J Macleod, S Mezher and R Hasan Since the dawn of the COVID-19 crisis, drastic changes have swept across many organisations. Healthcare providers are particularly affected by this; which we have experienced first-hand working in cardiac surgery. Working in this constantly evolving situation inevitably leads to uncertainty, inconsistency and even fear despite the best […]

Read More…

CoViD-19: Time to rethink the RCT and consider more efficient and ethical approaches to clinical knowledge acquisition

By Michael Keane. A recent, much publicized, randomized controlled trial (RCT) demonstrated that the corticosteroid, dexamethasone, reduced mortality from CoViD-19. This was hailed as a practice-changing breakthrough. The authors announced that “RECOVERY is a large, pragmatic, randomized, controlled adaptive platform trial designed to provide rapid and robust assessment of the impact of readily available potential […]

Read More…